Drug intelligence / Profile preview

Hayfever Care

Development stage: Preclinical
Lead developer: Innowage
Administration: Oral

Overview

Hayfever Care is a powdered natural food supplement, administered orally as a decoction, intended for the management of symptoms associated with seasonal allergic rhinitis. It is currently undergoing evaluation in a waitlist-controlled clinical trial to assess its therapeutic effectiveness, tolerability, and safety. The product is developed by Innowage Limited.

Brand names: Hayfever Care

Beyond the preview

Go deeper on Hayfever Care.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hayfever Care.

Explore the full profile